Approval · Notice of Compliance 36649 · 2025
TRANDATE: Notice of Compliance 36649
Issued December 29, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 36649
- Date
- December 29, 2025
- Company
- Knight Therapeutics Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative: Change in product ownership
Products in this notice
Medicinal ingredients
- LABETALOL HCL 100 MG per TAB
- LABETALOL HCL 200 MG per TAB